19-Aug-2021
Download PDF
Aurobindo Pharma
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 19 2021 for Axis Clinicals Limited (jointly holding with Trident Chemphar Limited and RPR Sons Advisors Pvt.Ltd)
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
